METHODES DE TRAITEMENT DE TROUBLES DU SYSTEME NERVEUX CENTRAL PAR L'INTERMEDIAIRE DE L'ADMINISTRATION DE NANOPARTICULES D'UN INHIBITEUR DE MTOR ET D'UNE ALBUMINE
The present application provides methods of treating a CNS disorder (such as glioblastoma and epilepsy) in an individual, comprising systemically (e.g., intravenously or subcutaneously) administering to the individual an effective amount of a composition comprising nanoparticles comprising an mTOR inhibitor (such as a limus drug, such as sirolimus or a derivative thereof) and an albumin, optionally further comprising administering a second agent (such as an anti-VEGF antibody, a proteasome inhibitor, or an alkylating agent).
